Quarterly ResultMay 14, 2026, 04:18 PM
Nu-Med Plus Reports Q1 Net Loss of $15,878; Going Concern Warning
AI Summary
Nu-Med Plus, Inc. reported a net loss of $15,878 for the three months ended March 31, 2026, with no revenue generated. The company faces substantial doubt about its ability to continue as a going concern, requiring approximately $1.2 million in additional financing for the next twelve months to fund operations and product development, which is currently suspended. The company's current funding is only sufficient through June 30, 2026.
Key Highlights
- Net loss for Q1 2026 was $(15,878), compared to $(19,933) in Q1 2025.
- Operating expenses decreased to $13,151 in Q1 2026 from $18,700 in Q1 2025.
- Cash balance at March 31, 2026, was $4,284.
- Total assets at March 31, 2026, were $7,184.
- Total liabilities at March 31, 2026, were $294,340.
- Working capital deficiency at March 31, 2026, was $286,156.
- Requires $1.2 million in additional financing for the next 12 months.
- Currently funded through June 30, 2026.